Skip to search formSkip to main contentSkip to account menu

iosulamide

National Institutes of Health

Related topics

Related topics

3 relations

Broader (1)

Diatrizoate
Meglumineanalogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1983
1983
Quantitative evaluation of biliary x-ray contrast agents in computed tomography.
A CT scanner has been used to measure liver enhancement with two liver-directed contrast media, iodipamide and iosulamide, in… 
1982
1982
Time-density evaluation of the liver after iosulamide meglumine: a tissue-specific CT contrast agent.
Iosulamide meglumine, a new intravenous biliary contrast agent, was evaluated as a potential hepatic contrast agent utilizing… 
1982
1982
Failure of iosulamide to enhance hepatic tumors in rats.
Iosulamide, an experimental cholangiographic agent recently being evaluated for hepatic contrast enhancement in computed… 
1981
1981
The potential of iosulamide meglumine as a contrast material for intravenous cholangiography: an experimental study in dogs.
Because of relatively low acute toxicity, iosulamide meglumine has been recommended as an improved contrast material for… 
1981
1981
EVALUATION OF IOSULAMIDE FOR THE CONTRAST ENHANCEMENT OF HEPATIC TUMORS
1980
1980
Iosulamide: a new intravenous cholangiocholecystographic medium.
Iosulamide is a bis-benzoic analogue of metrizoate that shows clear advantages in animal tests over meglumine iodipamide. The… 
1980
1980
Iosulamide: human tolerance study of a new intravenous cholangiographic drug.
A simple dose-ranging human tolerance study of an experimental intravenous cholangiographic agent (iosulamide) was performed… 
1980
1980
Iosulamide: a new intravenous cholangiocholecystographic medium.
Iosulamide is a bis-benzoic analogue of metrizoate that shows clear advantages in animal tests over meglumine iodipamide. The… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)